Entry Detail



General Information

Database ID:exR0359234
RNA Name:ABCF2
RNA Type:mRNA
Chromosome:chr7
Starnd:-
Coordinate:
Start Site(bp):151207837End Site(bp):151227166
External Links:ENSG00000285292



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
COX7C
chr5
86617928
86620962
+
ABCF2
chr7
151207837
151227166
-
EIF3L
chr22
37848868
37889407
+
PROM1
chr4
15963076
16084378
-
MTG1
chr10
133394094
133422520
+
SPG11
chr15
44562696
44663678
-
SUV39H2
chr10
14878820
14904315
+
MAP4
chr3
47850690
48089272
-
BTBD2
chr19
1985438
2034881
-
TRAPPC12
chr2
3379675
3485094
+
DYNLL2
chr17
58083419
58095542
+
IL32
chr16
3065297
3082192
+
STAT5B
chr17
42199177
42276707
-
RPS4X
chrX
72255679
72277248
-
MCOLN1
chr19
7522624
7534009
+
OST4
chr2
27070472
27071654
-
SERPINE1
chr7
101127104
101139247
+
CCT4
chr2
61868085
61888671
-
ENO1
chr1
8861000
8879190
-
ELOVL5
chr6
53267398
53349179
-
CD164
chr6
109366514
109382467
-
SLC37A4
chr11
119024114
119030906
-
AL360181.3
chr10
133380017
133420271
+
PHIP
chr6
78934419
79078254
-
LPGAT1
chr1
211743457
211830763
-
BCAT2
chr19
48795062
48811029
-
UBB
chr17
16380798
16382745
+
ERMP1
chr9
5765076
5833117
-
UBE2Q1
chr1
154548577
154559028
-
SNRNP40
chr1
31259568
31296788
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-107
chr10
89592756
89592778
-
hsa-miR-625-5p
chr14
65471116
65471136
+
hsa-miR-423-5p
chr17
30117095
30117117
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005487.1
chr7
108598352
108639349
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.